Chemistry
How the Warburg Effect Describes Altered Glycolysis in Cancer Cells
Quick fact
Cancer cells can produce up to 200 times more lactate than normal cells, and this 'aerobic glycolysis' – named the Warburg effect – is the basis for the PET scan, a common cancer imaging technique that detects the high glucose uptake of tumors.
Why this is interesting
You've a cell that's starving for energy? Not really—cancer cells often churn through glucose at a furious pace, but they burn it in a way that seems to waste most of its potential. Why would a rapidly dividing cell choose a fuel-burning strategy that's so inefficient?
Read the full explanation
Understanding How the Warburg Effect Describes Altered Glycolysis in Cancer Cells
Imagine you have two ways to power a city: a high-efficiency power plant that requires a steady supply of oxygen, and a simpler, quicker generator that doesn't. Healthy cells mostly use the high-efficiency plant—oxidative phosphorylation—which burns glucose completely to carbon dioxide and water, yielding about 36 ATP per glucose. Cancer cells, however, often switch to the simpler generator—glycolysis—even when oxygen is plentiful. They break glucose down to pyruvate and then reduce it to lactate, yielding only 2 ATP per glucose. This seems wasteful, but it happens fast and produces building blocks for cell growth, such as nucleotides and amino acids. The Warburg effect is this preference for glycolysis over oxidative phosphorylation in the presence of oxygen, a hallmark of many cancer cells.
A deeper explanation
The Warburg effect is not just a random quirk; it's a consequence of oncogenic signaling and metabolic reprogramming. Many cancer cells express high levels of glucose transporters and glycolytic enzymes, driven by oncogenes like Ras and Myc. The transcription factor HIF-1α, which is stabilized even under normoxic conditions in some tumors, also upregulates glycolysis and suppresses mitochondrial respiration. Why would a cell favor the low-ATP-yield pathway? The high rate of glycolysis can still produce ATP quickly enough to meet demands, and the glycolytic intermediates are channeled into biosynthetic pathways (e.g., the pentose phosphate pathway for NADPH and ribose, and serine/glycine synthesis for one-carbon metabolism). Also, the production of lactate acidifies the tumor microenvironment, which can promote invasion and suppress immune responses. The mechanism is a prime example of how metabolism is rewired to support uncontrolled proliferation, and it provides targets for cancer therapy.